1/22
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
List the four specific components of the preparticipation evaluation, recommended by the American College of Sports Medicine
informed consent
exercise preparticipation screening
health history
cardiovascular risk factor analysis
Describe the required components of an informed consent document
Required components:
purpose and risk associated
participant may ask questions
withdrawal at anytime
efforts made to ensure privacy is protected
Describe the delivery of an informed consent document
Delivery:
should be completed prior to the collection of any personal or confidential information
before any form of fitness testing
exercise participation
Identify signs and symptoms of cardiometabolic diseases
pain
shortness of breath
dizziness or syncope
tachycardia
Determine if someone requires medical clearance before participating in an exercise program using the ACSM preparticipation screening algorithm
For individuals who do not participate in regular exercise with no known CV, metabolic, or renal disease medical clearance is not needed. But if there are known CV, metabolic, or renal disease or sign and symptoms of disease medical clearance in recommended
For individuals who do participate in regular exercise with no known CV, metabolic, or renal disease medical clearance is not needed. Medical clearance if only need if there are any sign or symptoms of CV, metabolic, or renal disease.
Define light PA in terms of METs, %HRR and %VO2R, and RPE
2-2.9METs, 30-39% of %HHR or %VO2R, RPE 9-11
Define moderate PA in terms of METs, %HRR and %VO2R, and RPE
3-5.9METs, 40-59% of %HHR or %VO2R, RPE 12-13
Define vigorous PA in terms of METs, %HRR and %VO2R, and RPE
>6 METS, >60% of %HHR or %VO2R, RPE >14
Positive cardiovascular disease (CVD) risk factor: AGE
Men > 45 and women >55
Positive cardiovascular disease (CVD) risk factor: BLOOD GLUCOSE
Fasting plasma glucose >100mg
Positive cardiovascular disease (CVD) risk factor: LIPIDS
LDL-C >130mg, HDL-C <40mg, Total cholesterol >200mg
Positive cardiovascular disease (CVD) risk factor: BLOOD PRESSURE
systolic blood pressure >130mmHg or diastolic > 80 mmHg
Positive cardiovascular disease (CVD) risk factor: BMI / WAIST CIRCUFERENCE
BMI of >30kg or men waist >40in and female >35in
Positive cardiovascular disease (CVD) risk factor: PHYSICAL INACTIVITY
not meeting 150-300 moderate or 75 -150 vigorous
Positive cardiovascular disease (CVD) risk factor: FAMILY HISTORY
myocardial infarction, or sudden death before 55 in father or male first-degree relative or before 65 in mother or first degree relative
Positive cardiovascular disease (CVD) risk factor: CIGARETTE SMOKING
Current smoking or who have quite within the last 6 months or environmental tobacco exposure
List and describe the negative cardiovascular disease (CVD) risk factors
HDL-C: >60mg
Classify blood pressure as normal on the ACC/AHA criteria for adults
<120/<80
Classify blood pressure as elevated on the ACC/AHA criteria for adults
SBP:120-129 and DBP: <80
Classify blood pressure as stage 1 hypertension on the ACC/AHA criteria for adults
SBP: 130-139 and DBP: 80-89
Classify blood pressure as stage 2 hypertension on the ACC/AHA criteria for adults
>140/>90
Health screening finds individuals at risk for exercise-related CV events are:
individuals that need
clearance for moderate to vigorous exercise or increases in intensity
require participation in a supervised exercise program
cannot participate in an exercise program until condition improves
How to identify higher-risk individuals using ACSM preparation screening algorithm by:
current PA participation level
presence of sign or symptom and known CV, metabolic, or renal disease
anticipated or desired exercise intensity